The Tau-induced decrease in NMDA receptor mobility may influence the clustering and trafficking of NMDA receptors in and into dendritic spines, which may contribute to synaptic dysfunction in Alzheimer’s disease (Fig. 5). The gene discussed is MAPT; the disease is Alzheimer disease.